PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 12 of these applications claim priority to application 62/692,591, filed Jun 29, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,834,539 | PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors In force · High confidence | Forma Therapeutics, Inc. | In force | High confidence | ||
| US 10,414,752 | PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors In force · Low confidence | Forma Therapeutics, Inc. | In force | Low confidence | ||
| US 10,550,098 | PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors In force · Low confidence | Forma Therapeutics, Inc. | In force | Low confidence | ||
| US 10,889,567 | PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors In force · Low confidence | Forma Therapeutics, Inc. | In force | Low confidence | ||
| US 11,498,913 | PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors In force · Low confidence | Forma Therapeutics, Inc. | In force | Low confidence | ||
| US 12,275,715 | PYRIDIN-2(1H)-ONE Quinolinone Derivatives as Mutant-Isocitrate Dehydrogenase Inhibitors In force · Low confidence | Forma Therapeutics, Inc. | In force | Low confidence | ||
| US 10,532,047 | Solid Forms of ((S)-5-((1-(6-Chloro-2-OXO-1,2-Dihydroquinolin-3-YL)ETHYL)AMINO)-1-Methyl-6-OXO-1,6-Dihydropyridine-2-Carbonitrile In force · High confidence | Forma Therapeutics, Inc. | In force | High confidence | ||
| US 10,959,994 | Solid Forms of ((S)-5-((1-(6-Chloro-2-OXO-1,2-Dihydroquinolin-3-YL)ETHYL)AMINO)-1-Methyl-6-OXO-1,6-Dihydropyridine-2-Carbonitrile In force · High confidence | Forma Therapeutics, Inc. | In force | High confidence | ||
| US 11,013,733 | Inhibiting Mutant Isocitrate Dehydrogenase 1 (mIDH-1) In force · High confidence | Forma Therapeutics, Inc. | In force | High confidence | ||
| US 11,013,734 | Treating Patients Harboring an Isocitrate DEHYDROGENASE-1 (IDH-1) Mutation In force · High confidence | Forma Therapeutics, Inc. | In force | High confidence | ||
| 19 more patents in this group · Pro | ||||||
10 of 29 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 29.
18 of these are in force and held by Forma Therapeutics, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.